References
- Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson memorial lecture. Am J Ophthalmol. 2011;151(2):212–241. doi:10.1016/j.ajo.2010.10.018.
- Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of ocular complications of AIDS research group in collaboration with the AIDS clinical trials group. Ophthalmology. 1994;101(7):1250–1261.
- Chan NSW, Chee SP, Caspers L, Bodaghi B. Clinical features of CMV-associated anterior uveitis. Ocul Immunol Inflamm. 2018;26(1):107–115. doi:10.1080/09273948.2017.1394471.
- Relvas LJ, Caspers L, Chee SP, Zierhut M, Willermain F. Differential diagnosis of viral-induced anterior uveitis. Ocul Immunol Inflamm. 2018;26(5):726–731. doi:10.1080/09273948.2018.1468470.
- Schneider EW, Elner SG, Van Kuijk FJ, et al. Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina. 2013;33(9):1791–1799. doi:10.1097/IAE.0b013e318285f486.
- Ho M, Invernizzi A, Zagora S, et al. Presenting features, treatment and clinical outcomes of cytomegalovirus retinitis: non-HIV patients vs HIV patients. Ocul Immunol Inflamm. 2020;28(4):651–658. doi:10.1080/09273948.2019.1604003.
- Downes KM, Tarasewicz D, Weisberg LJ, Cunningham ET. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients—case report and comprehensive review of the literature. J Ophthalmic Inflamm Infect. 2016;6(1):1–19. doi:10.1186/s12348-016-0070-7.
- Zhou YF, Shou M, Guetta E, et al. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation. 1999;100(14):1569–1575. doi:10.1161/01.cir.100.14.1569.
- Rao NA, Zhang J, Ishimoto SI, Jabs DA, Green WR, Pulido J. Role of retinal vascular endothelial cells in development of CMV retinitis. Trans Am Ophthalmol Soc. 1998;96:111–126.
- Pierce B, Richardson CL, Lacloche L, Allen A, Ison MG. Safety and efficacy of foscarnet for the management of ganciclovir-resistant or refractory cytomegalovirus infections: a single-center study. Transpl Infect Dis. 2018;20(2):e12852. doi:10.1111/tid.12852.
- Danner SA. Management of cytomegalovirus disease. AIDS. 1995;9:S3–S8.
- Tognon MS, Turrini B, Masiero G, et al. Intravitreal and systemic foscarnet in the treatment of AIDS-related CMV retinitis. Eur J Ophthalmol. 1996;6(2):179–182. doi:10.1177/112067219600600215.
- Invernizzi A, Agarwal AK, Ravera V, et al. Comparing optical coherence tomography findings in different aetiologies of infectious necrotising retinitis. Br J Ophthalmol. 2018;102(4):433–437. doi:10.1136/bjophthalmol-2017-310210.